The National Agency for Food and Drug Administration and Control (NAFDAC) has approved Pfizer COVID-19 vaccine for use in Nigeria.
NAFDAC, however, explained that the Pfizer vaccine is for emergency use.
The Director-General of the agency, Mojisola Adeyeye confirmed this during a virtual meeting on Friday in Abuja.
Earlier in March, Nigeria had received 3.9 million doses of the Astranezeneca jabs and flagged off the vaccination exercise during an event organized by the National Primary Health Care Development Agency (NPHCDA) in Abuja.
Since the vaccination campaign began, over 600, 000 persons have taken the jab, as the country records a lower number of infections.